GlaxoSmithKline PLC stock price, GSK

GlaxoSmithKline PLC stock chart:



GlaxoSmithKline PLC close price: 43.26

Stock price forecast:

DOWN TO -0.76%
Target: 42.93

Total forecasts: 84
Reached: 15 (17.86%)

Total Win: 12.30 (29.40%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90851517.65%12.300.35%2,979.08-49.12-1.65%-36.82-1.02%
303100.00%0.000.00%1,341.060.000.00%0.000.00%
141500.00%0.000.00%648.900.000.00%0.000.00%
7800.00%0.000.00%346.080.000.00%0.000.00%

Showing 1-10 of 592 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-06-2643.2642.930000-00-00
2017-06-2543.2642.930000-00-00
2017-06-2443.2642.920000-00-00
2017-06-2343.2642.920000-00-00
2017-06-2243.2642.970000-00-00
2017-06-2143.2642.970000-00-00
2017-06-2043.2642.970000-00-00
2017-06-1943.2643.060000-00-00
2017-06-1843.2643.060000-00-00
2017-06-1743.2643.060000-00-00

GlaxoSmithKline PLC latest news:


  • 06/22/2017 13:20:00

    New GSK chief Walmsley eyes MaxiMuscle sale

    The new chief executive of GlaxoSmithKline (GSK) is kicking off her tenure with a move to offload the division which owns Maximuscle, a nutritional products brand favoured by elite athletes.

  • 06/19/2017 10:26:37

    GSK's new pharma head to join in September after AstraZeneca tussle

    LONDON (Reuters) - GlaxoSmithKline has struck a deal for Luke Miels to start as its new head of pharmaceuticals in September, following a lengthy dispute over his contract with his former employer AstraZeneca.

  • 05/10/2017 10:35:09

    Mylan disagrees with FDA over generic Advair rejection

    (Reuters) - Generic drug maker Mylan NV said on Wednesday it disagrees with the U.S. Food and Drug Administration, which declined to approve Mylan's generic for GlaxoSmithKline Plc's blockbuster Advair in March.

  • 03/31/2017 16:59:07

    Mylan Receives CRL for Generic Advair Diskus From the FDA

    Mylan N V MYL recently suffered a huge setback The company received a complete response letter from the FDA regarding its abbreviated new drug application ANDA for the generic version of GlaxoSmithKline s GSK asthma drug Advair Diskus The company is in the process of reviewing

  • More trends:

    Global Brass and Copper HoldingsBRSS | Global Cash Access HoldingsGCA | Global High Income Dollar FundGHI | Global Net LeaseGNL | Global Partners LPGLP | Global Payments Inc.GPN | Global Power Equipment Group IncGLPW | Global Ship LeaseGSL | Global Ship LeaseGSL^B | Globant S.A.GLOB |